Viking Therapeutics Inc’s shares gained about 15% premarket on Thursday after the company signaled progress on an experimental obesity drug that could accelerate its development timeline.
More Stories
Mortgage rates fall to lowest level in two years: Here’s how much money you need to buy a $400,000 home
The 30-year mortgage rate is averaging 6.09%, Freddie Mac said in its latest weekly survey on Thursday.
Bond spreads for ‘Magnificent Seven’ tighten as investors celebrate interest-rate cut
“As frequent bond issuers, big tech loves lower rates.”
Nvidia’s stock is surging. Here’s how it tends to perform after interest-rate cuts.
Nvidia’s stock historically has made dramatic moves in the year after initial Fed interest-rate cuts, and it has outperformed the...
Bank stocks join market rally. Analyst cites boost to lenders’ balance sheets.
Bank stocks moved up on Thursday as they added to gains from the previous session on the heels of the...
These tips for investing in mutual funds and ETFs can help you ride with the Fed
Gold glitters, while investors face recession jitters.
JetBlue Airways to open its first premium customer lounges in New York and Boston
Airline said it is responding to growing demand for “premium” perks.